أعرض في EDS

S831 CPI-0610, A BROMODOMAIN AND EXTRATERMINAL DOMAIN (BET) INHIBITOR, REDUCES PRO-INFLAMMATORY CYTOKINES, BONE MARROW FIBROSIS AND THE NUMBER OF TRANSFUSIONS IN MYELOFIBROSIS PATIENTS

التفاصيل البيبلوغرافية
العنوان: S831 CPI-0610, A BROMODOMAIN AND EXTRATERMINAL DOMAIN (BET) INHIBITOR, REDUCES PRO-INFLAMMATORY CYTOKINES, BONE MARROW FIBROSIS AND THE NUMBER OF TRANSFUSIONS IN MYELOFIBROSIS PATIENTS
المؤلفون: S. Verstovsek, J. Mertz, John Mascarenhas, V. Gupta, G. Schiller, S. Kabir, Robert S. Hoffman, J. Supko, J. Piel, C. Lebedinsky, Patrick Trojer, P. Bose, A. Senderowicz, A. Godfrey, E. Liew, Marina Kremyanskaya
المصدر: HemaSphere. 3:369
بيانات النشر: Ovid Technologies (Wolters Kluwer Health), 2019.
سنة النشر: 2019
مصطلحات موضوعية: BET inhibitor, business.industry, medicine, Cancer research, Bone marrow fibrosis, Hematology, Myelofibrosis, medicine.disease, business, Proinflammatory cytokine, Bromodomain, Domain (software engineering)
تدمد: 2572-9241
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2b68c23842e9ce85c790783ded2de69b
https://doi.org/10.1097/01.hs9.0000561604.66251.2e
حقوق: OPEN
رقم الأكسشن: edsair.doi...........2b68c23842e9ce85c790783ded2de69b
قاعدة البيانات: OpenAIRE
الوصف
تدمد:25729241